LAWRENCE G. LUM, MD

Plain English
This study focused on creating a standardized set of outcomes to be measured in clinical trials for dengue, a rapidly spreading disease caused by a virus transmitted by mosquitoes. Researchers gathered input from various experts and individuals with experience of dengue, ultimately agreeing on a Core Outcome Measurement Set (COMS) that includes seven key outcomes for hospitalized patients, with four additional ones for those in the early stages of the disease. This is important because it helps ensure that future dengue research is consistent and can be easily compared, which can improve treatment decisions and patient care. Who this helps: This helps patients with dengue and their doctors by providing clearer and more consistent ways to measure treatment effectiveness.

Plain English
This study focused on creating new mouse models of cutaneous squamous cell carcinoma, a type of skin cancer that can be as deadly as melanoma. Researchers developed 11 tumor lines that mimic important features of human skin cancer, finding that some tumors had a strong immune response while others had a weak one. These models are important because they can help improve immunotherapy treatments that currently work for only about half of skin cancer patients. Who this helps: This benefits doctors and researchers working to treat skin cancer patients.

Plain English
This study looked at how different types of cells within tumors affect the body's immune response to cancer treatment. Researchers found that areas of tumors with "cold" cells (which are less responsive to immune attack) suppressed immune activity, making the treatment less effective. Specifically, in mixed tumors, the cold regions led to poorer immune responses, even after treatment, because of certain signals from the cold cells. Who this helps: This research helps doctors understand how to improve immunotherapy for cancer patients by targeting these cold tumor areas.

Plain English
Researchers developed a new set of 11 skin cancer cell lines, called CIT lines, which closely mimic cutaneous squamous cell carcinoma (cSCC), a type of skin cancer that causes many deaths each year. These lines were created from skin tumors caused by specific chemical treatments and show different patterns of immune response, with some tumors being more responsive to immunotherapy than others. This is important because it provides better tools to understand and improve treatments for cSCC, potentially increasing success rates for patients. Who this helps: This benefits patients with cutaneous squamous cell carcinoma and doctors seeking more effective treatment options.

Plain English
This study focused on the role of a protein called tankyrase in a cellular process linked to cancer growth, specifically how it affects the destruction of another protein, β-catenin, which is involved in tumor development. The researchers found that current treatments that inhibit tankyrase don’t work well because they cause a buildup of certain cellular structures that interfere with β-catenin's breakdown. By using a method to degrade tankyrase instead, they were able to more effectively reduce the activity of the WNT/β-catenin pathway and slow down the growth of colorectal cancer cells that have specific mutations. Who this helps: This benefits cancer patients, particularly those with colorectal cancer and mutations affecting the WNT/β-catenin pathway.

Plain English
This study looked at how certain immune cells, especially macrophages, affect the response of advanced kidney cancer (renal cell carcinoma) to immunotherapy. Researchers found that these immune cells are influenced by specific signaling molecules called interferons. In more than 800 cancer patients, they discovered that signals from macrophages were linked to resistance to treatment, with myeloid cell activity being a key factor. This matters because understanding these mechanisms can help improve immunotherapy effectiveness for kidney cancer patients. Who this helps: Patients with advanced renal cell carcinoma.

Plain English
This study looked at how including both parents in a smartphone app aimed at preventing postpartum depression could improve its effectiveness. Interviewees said that providing the app to both moms and dads at the same time would make it more helpful. This matters because it highlights the importance of involving partners in mental health support during the postpartum period. Who this helps: This helps new parents and their partners by promoting shared mental health care.

Plain English
This study looked at a drug called pascolizumab, which blocks a substance called IL-4 that might make it harder for the body to fight tuberculosis. Researchers tested pascolizumab alongside standard treatment in patients with a form of tuberculosis that can be treated with rifampicin. They found that while there were no serious safety issues, the time it took for patients' sputum cultures to become positive was about the same (42 days) for both pascolizumab and a placebo, although the rate of improvement was slightly better with pascolizumab. Who this helps: This research benefits patients with tuberculosis.

Plain English
This study looked at how adding realistic teamwork simulations to a basic CPR training course could help medical students improve their skills in working as a team during emergencies. Out of 24 students, 21 (about 88%) found that while they felt equally skilled in basic CPR tasks from both training sessions, they credited the simulations for improving their leadership and communication skills. This matters because it can lead to better teamwork in real-life medical emergencies, ultimately improving patient care. Who this helps: This benefits medical students and healthcare professionals involved in emergency care.

Plain English
This research studied how CRISPR technology can speed up the process of finding genes that cause cancer. The researchers used CRISPR to analyze many genes at once and discovered that it helps identify cancer-promoting genes more efficiently. This is important because it can lead to faster development of targeted cancer treatments. Who this helps: This benefits patients by potentially leading to more effective cancer therapies.

Plain English
This study focused on creating a smartphone app called MBapp to help prevent postpartum depression (PPD) in low-income pregnant individuals. By gathering feedback from 25 users, the researchers improved the app by adding features like audio narration and the option to ask a clinician nonurgent questions. This matters because it enhances an effective treatment for PPD, making it more accessible and engaging for potential users. Who this helps: This benefits pregnant individuals at risk of postpartum depression.

Plain English
This study looked at how the immune responses in the blood of men with advanced prostate cancer relate to their survival after receiving a specific therapy called sipuleucel-T. Researchers found that men who had a strong immune response (measured by the release of a protein called IFN-β) after being treated with a type of immune signal had significantly longer survival rates; for instance, in one group of 106 men, those with high responses had a survival risk reduced by 88% compared to others. It appears that Black men showed stronger immune responses, which also correlated with better survival outcomes, regardless of other factors. Who this helps: This research benefits patients, particularly Black men with metastatic prostate cancer, by providing insights into how their immune response affects their treatment outcomes.

Plain English
This study evaluated a COVID Virtual Ward designed to manage elderly and immunocompromised patients in Singapore. Out of 238 patients admitted, only 17.2% needed to go to the hospital and just 2.1% died, showing that the program effectively monitored high-risk patients at home. This approach matters because it alleviates pressure on hospitals while ensuring these patients receive appropriate care. Who this helps: This helps elderly and immunocompromised patients during COVID-19.

Plain English
This study looked at how different types of cells within a tumor affect the body's immune response to cancer treatment, specifically in squamous cell skin cancers. Researchers found that areas with "hot" tumor cells had more immune cells that fight cancer, while areas with "cold" tumor cells had fewer and more suppressive immune cells. This difference can lead to treatments being less effective, as the presence of cold tumor cells prevents the therapy from working as well as it could. Who this helps: This helps patients with squamous cell skin carcinoma and doctors treating them.

Plain English
Researchers studied how women felt about their experiences with labor induction at a hospital. They interviewed 36 women and found that opinions on the process varied widely; some described their experiences as "horrible" or "frustrating," while others found it "simple" or "fast." Many women mentioned that labor induction took longer than they expected and expressed concerns about their babies' health, showing that being informed and involved in decisions could lead to better experiences. Who this helps: This study helps expectant mothers and healthcare providers improve the labor induction experience.

Plain English
In this study, researchers tested a new method called the dTAG system to remove two specific proteins, CDK2 and CDK5, from adult mice and looked into its safety. They found that using dTAG-13 led to a quick and significant removal of these proteins in various organs without harming the mice's overall health; specifically, no serious side effects were noted except for some minor changes observed in the testes of mice with CDK2 loss. This matters because it shows that dTAG is an effective way to study protein function without the risks associated with traditional genetic methods. Who this helps: This benefits researchers and scientists studying protein roles in diseases.

Plain English
This study looked at how a special type of laser treatment can improve the properties of waste carbon powder, which is a common type of carbon material. The researchers found that using the laser made the carbon much more electrically conductive, with increases of up to 90% in some cases. The laser needs to be set at the right power level; too low or too high can either do nothing or damage the material. Who this helps: This benefits researchers and industries looking for better materials for electronic devices.

Plain English
This study looked at how different drugs that block the PARP1 enzyme, which is important for repairing DNA, work in the context of cancer treatment. The researchers found that the drug talazoparib is particularly effective not just against PARP1 but also shows a strong interaction with another protein called TNKS1, which is important for a cancer-related pathway. This matters because understanding these interactions can help in developing better drugs for certain types of cancers, like colorectal cancer. Who this helps: This helps patients with colorectal cancer and doctors treating them.

Plain English
This study explored new cancer immunotherapy strategies that specifically target a protein called Integrin β4 (ITGB4), which is important for cancer stem cells. Researchers found that two different treatments—vaccination with ITGB4 proteins and special T cells designed to attack ITGB4—greatly reduced tumor growth and spread in mice models of breast and head and neck cancers. This is significant because it means these treatments can potentially offer more effective ways to fight various cancers, especially since they showed no harmful side effects in the mice. Who this helps: This helps cancer patients, particularly those with tumors that express Integrin β4.

Plain English
This study looks at how the National University Hospital in Singapore quickly organized its infectious diseases team to respond to the COVID-19 pandemic right after the first case was reported. Within two months, the hospital managed 3,030 suspected cases, tested 4,384 samples, and treated 1,300 patients. This is important because it shows how hospitals can effectively adapt and maintain standards of care during a public health crisis, which can guide other hospitals around the world in similar situations. Who this helps: This helps patients and healthcare workers in hospitals responding to infectious disease outbreaks.

Plain English
This study looked at invasive fungal diseases (IFD) in liver transplant patients, analyzing data from 554 adults who underwent transplants between 2005 and 2015. The researchers found that 5.1% of these patients developed IFD, with the most common infections being Candidiasis (39.3%) and Aspergillosis (35.7%). Understanding these infections and their risk factors, such as needing a reoperation or receiving a large blood transfusion, is crucial because it can help improve patient care and reduce complications after liver transplants. Who this helps: This helps patients and doctors by identifying risks and improving treatment options following liver transplantation.

Plain English
This study looked at how a protein called PAGE4 affects a signaling pathway known as Wnt/β-catenin, which is important for development and maintaining healthy tissues. Researchers found that PAGE4 can effectively block another protein, Tankyrase, which normally promotes Wnt/β-catenin activity, in human cells and in animals like zebrafish and mice. By doing this, PAGE4 helps control the signaling process specifically in prostate tissue, which is crucial for regulating cell behaviors in that area. Who this helps: This research benefits patients with prostate-related conditions, as understanding this signaling pathway could lead to new treatments.

Plain English
This study looked at how giving the antibiotic meropenem in less frequent doses (intermittently) affects stable patients undergoing hemodialysis. It found that those on intermittent dosing had a shorter average hospital stay of about 15.5 days compared to 30.2 days for those receiving daily doses, but they had a higher rate of being readmitted within 30 days (50% versus 38.2%). This is important because it suggests that intermittent dosing can help patients leave the hospital sooner, but it also raises questions about their ongoing care after discharge. Who this helps: This benefits patients on hemodialysis who need antibiotic treatment.

Plain English
This study looked at how a specific protein called MLL-AF9 influences the development of a type of blood cancer known as acute myelocytic leukemia (AML). Researchers found that MLL-AF9 activates a pathway called WNT/SIX1, which helps cancer cells grow. When they used new drugs to block this pathway, they observed that the growth of leukemia cells was slowed down significantly. Who this helps: This research benefits patients with acute myelocytic leukemia by identifying potential new treatments to slow down or stop their cancer.

Plain English
This study looked at how a specific type of fat, known as fatty acyl chains, is crucial for the release of WNT proteins from an enzyme called Porcupine (PORCN). Researchers found that a certain fatty acid, called omega-9, is essential for properly processing these WNT proteins, and if this fatty acid is altered, it can cause an accumulation of these proteins that are normally secreted. This is important because it helps us understand how WNT signaling works, which could have implications for treating diseases related to this pathway. Who this helps: This benefits researchers and doctors developing treatments for conditions involving WNT signaling, such as cancer and developmental disorders.

Plain English
This study looked at how CRISPR-Cas9, a tool for editing genes, often causes unexpected changes in the messenger RNA (mRNA) that can lead to the production of incorrect proteins. Researchers found that about 50% of the cell lines they tested showed signs of these unwanted mRNAs or proteins due to errors made during the gene editing process. Understanding these issues is crucial because they highlight the potential risks of using CRISPR-Cas9 for precise genetic changes and offer ways to improve its accuracy. Who this helps: This helps researchers and doctors working with gene therapies.

Plain English
This study focused on a new chemical agent called IHR-SAHA, which targets two important parts of cancer cell signaling related to basal cell carcinoma and medulloblastoma. Researchers found that IHR-SAHA effectively blocks cancer growth processes driven by both Smoothened (SMO) and GLI proteins, which are often resistant to other treatments. This approach could help keep cancer in remission longer and offers a promising way to develop more effective combined therapies. Who this helps: This benefits patients with basal cell carcinoma and medulloblastoma.

Plain English
This study focused on how WNT proteins influence cancer behavior and how they can be targeted in treatments, especially in melanoma, where they might help cancers escape the immune system. Researchers reviewed existing information and noted that chemicals designed to block certain WNT processes, particularly those affecting a target called porcupine, are now being tested in patients, with two of them currently in clinical trials. Understanding and manipulating WNT signaling could lead to more effective cancer treatments with fewer side effects. Who this helps: This helps cancer patients, especially those with melanoma.

Plain English
The study focused on two types of germ cell tumors (GCT): seminomas and nonseminomatous germ cell tumors (NSGCT). Researchers discovered that NSGCTs, which include types like embryonal carcinoma and yolk sac tumors, have a key signaling pathway called mTORC1 that is active, while seminomas do not. They found that using two drugs, erlotinib and rapamycin, together significantly slowed the growth of NSGCT cells, indicating they could be effective treatment options for these tumors. Who this helps: This benefits patients with nonseminomatous germ cell tumors.

Plain English
This study focused on tankyrases, which are enzymes that modify proteins and play a key role in cell signaling, especially related to the Wnt/β-catenin pathway. Researchers found that tankyrase activity is influenced by a specific interaction between two halves of the enzyme, suggesting that they work best when linked together in a particular way. Understanding this mechanism is important because it helps clarify how tankyrase functions and could lead to better targeting of these enzymes in diseases like cancer where this pathway is involved. Who this helps: This research benefits scientists and doctors working on cancer therapies.

Plain English
This study looked at a drug called WNT-974, which blocks a specific protein to explore how it affects heart tissue recovery after injury. Researchers found that WNT-974 improved heart function by reducing scar tissue and a harmful collagen protein in damaged areas, showing a significant reduction in scarring. This matters because it suggests that using this type of drug could help heal the heart after a heart attack. Who this helps: This helps patients recovering from heart attacks.

Plain English
This study looked at how critically ill children are cared for in Southeast Asia, a region facing significant challenges due to differences in health systems and high infant and child mortality rates. It found that there are gaps in care delivery, especially in emergency services and hospital treatment, indicating that improvements are needed for better outcomes. The researchers recommend strengthening health systems and creating low-cost solutions that are suited to local needs to enhance the care of these young patients. Who this helps: This benefits critically ill children and their families in Southeast Asia by improving their access to essential health care.

Plain English
This study looked at how certain proteins related to cell survival, specifically three BCL-2 proteins, affect cancer growth by interacting with a tumor suppressor protein called SUFU. The researchers found that these BCL-2 proteins help cancer cells survive by promoting changes that lead to the expression of genes that support growth and survival, effectively overriding the tumor-suppressing effects of SUFU. Understanding this process is important because it reveals a potential new way to overcome resistance to treatments in tumors associated with the GLI proteins. Who this helps: This helps cancer patients and doctors by providing new targets for treatment strategies.

Plain English
This study looked at how intravenous (IV) fluid treatment affects patients with dengue fever, especially those experiencing serious complications like fluid buildup and respiratory distress. Out of over 1,700 patients, 88% never developed severe shock, but among those who did, a significant 84% showed signs of fluid accumulation. Importantly, as the amount of IV fluid infused increased, the risk of developing respiratory issues also rose sharply, underscoring the need for careful management of fluid therapy in these patients. Who this helps: This research helps doctors managing dengue patients to make safer decisions about fluid treatment.

Plain English
This study looked at how internationally educated nurses feel about their English language skills and communication needs while training in Canada. Researchers spoke to 22 nurses from countries like the Philippines and Nigeria, and many expressed difficulty in adjusting to Canadian professional standards and communication requirements, which were often different from what they were used to. The findings highlight the need for better support and clearer information about language expectations before these nurses arrive in Canada, to help them integrate more smoothly into the healthcare system. Who this helps: This helps internationally educated nurses transitioning to practice in Canada.

Plain English
This study focused on a new method for tracking modifications to Wnt proteins, which play a role in cell signaling. Researchers developed a technique that allows them to see how these proteins are chemically altered, using a special reaction that simplifies the process and reduces interference from other proteins. Their method improves the accuracy of their measurements, making it easier to study the Wnt proteins. Who this helps: This benefits researchers studying cell signaling and potential therapies related to Wnt proteins.

Plain English
This study looked into a method for giving a drug called WNT974 to mice. The researchers found that by giving the drug once a day for three months, they could effectively reduce certain biological signals in the body without causing significant weight loss, indicating low toxicity. This method is important because it allows for a longer and safer treatment time in animal studies, which can help in developing therapies for diseases like cancer. Who this helps: This helps doctors and researchers developing new cancer treatments.

Plain English
This study focused on creating a new type of drug that can inhibit an enzyme called Porcupine, which is important for the growth and repair of tissues as well as for cancer development. Researchers developed a new drug named IWP-O1 that is very effective, showing a potency value of 80 picomoles, which means it works really well at very low concentrations. This advancement is important because IWP-O1 also lasts longer in the body than earlier versions of Porcn inhibitors, potentially improving treatment outcomes for various diseases. Who this helps: Patients with cancer and other conditions linked to Wnt proteins.

Plain English
This study looked at a protein complex called the exocyst, specifically focusing on one of its components, Sec6/8, to understand its role in maintaining the stability of our DNA. Researchers found that damaging this complex made cells more resistant to radiation and allowed DNA damage to heal faster, but it also led to more errors in DNA repairs and a risk of genetic problems. These findings are important because they reveal how the exocyst helps control proper DNA repair, which is crucial for preventing diseases like cancer. Who this helps: This helps doctors and researchers who are working to improve cancer treatments.

Plain English
This research looked at how certain cell-signaling molecules called Wnt proteins affect how cells decide to become different types of cells, which is important for both cancer treatment and regenerative medicine. The study highlighted two specific small molecules that target components of the Wnt pathway, showing that these could help us better understand how to develop new drugs that steer cell behavior. This matters because it opens the door to innovative treatments for diseases like cancer, improving the way we can guide cell development in therapies. Who this helps: This helps patients undergoing cancer treatment and those needing regenerative therapies.